Company Filing History:
Years Active: 2002
Title: Janice Kurth: Innovator in Genetic Research
Introduction
Janice Kurth is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of genetic research, particularly in understanding drug metabolism through genetic polymorphisms.
Latest Patents
Janice holds a patent for "Genotyping the human phenol sulfotransferase 2 gene STP2." This patent identifies genetic polymorphisms in the human STP2 gene that can alter drug metabolism. The nucleic acids comprising these polymorphic sequences are utilized to screen patients for altered metabolism of STP2 substrates, potential drug-drug interactions, and adverse side effects. Additionally, her work addresses diseases resulting from environmental or occupational exposure to toxins. The nucleic acids are also employed to establish animal, cell, and in vitro models for drug metabolism.
Career Highlights
Janice is currently associated with Dna Sciences Laboratories, Inc., where she continues her research and development in genetic studies. Her work has been instrumental in advancing the understanding of how genetic variations can impact drug efficacy and safety.
Collaborations
Janice collaborates with Marco Guida, enhancing the research efforts at Dna Sciences Laboratories, Inc. Their combined expertise contributes to innovative solutions in the field of genetics.
Conclusion
Janice Kurth's work in genetic research exemplifies the impact of innovation on healthcare and drug development. Her contributions are paving the way for improved patient care through personalized medicine.